Pomerantz Llp Shares Class Action Details With Shareholders In Baxter International, Inc. - Bax

NEW YORK CITY, NY / ACCESS Newswire / December 5, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Baxter International, Inc. ("Baxter" or the "Company") . Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

The class action concerns whether Baxter and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

You have until December 15, 2025, to ask the Court to appoint you as Lead Plaintiff for the class if you purchased or otherwise acquired Baxter securities during the Class Period. A copy of the Complaint can be obtained at www.pomerantzlaw.com.

[Click here for information about joining the class action]

On July 31, 2025, Baxter announced that it had decided to "voluntarily and temporarily pause shipments and planned installations of the Novum LVP", a medical device used for the controlled delivery of intravenous fluids, and that the Company was "unable to currently commit to an exact timing for resuming shipment and installation for Novum IQ LVPs." Baxter stated that they had offered "customers the option of our Spectrum infusion pump as an alternative" and that the Company's low-end guidance assumes that the Company does not resume shipments for Novum LVPs before the end of the year.

On this news, Baxter's stock price fell $6.29 per share, or 22.4%, to close at $21.76 per share on July 31, 2025.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising. Prior results do not guarantee similar outcomes.

SOURCE: Pomerantz LLP

View the original press release on ACCESS Newswire

NEW YORK, NY / ACCESS Newswire / December 5, 2025 / - SueWallSt: Class Action Filed Against Baxter International, Inc. - Contact Levi & Korsinsky

A Class Action lawsuit was filed on behalf of investors who lost money as a result of alleged securities fraud between February 23, 2022 and July 30, 2025.

If you suffered a loss in Baxter International, Inc., don't stay silent. Take action now by visiting:

https://zlk.com/suewallst2?wire=1

If you have any questions about this class action lawsuit or any other sudden or unexpected stock loss, email lostmoney@suewallst.com or call Levi & Korsinsky at (888)-SUE-WALLST (783-9255).

Get more information on this and other class action lawsuits on the SueWallSt podcast and subscribe to the SueWallst WhatsApp channel for breaking class action news.

SueWallSt Channel

LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

Ed Korsinsky, Esq.

33 Whitehall Street, 27th Floor

New York, NY 10004

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

https://zlk.com/

SOURCE: Levi & Korsinsky, LLP

View the original press release on ACCESS Newswire

NEW YORK, NY / ACCESS Newswire / December 5, 2025 / Levi & Korsinsky, LLP releases a Podcast regarding Baxter International, Inc. class action securities lawsuit

A Class Action lawsuit was filed on behalf of Baxter International, Inc. investors who lost money as a result of alleged securities fraud between February 23, 2022 and July 30, 2025.

Levi & Korsinsky has released a Podcast describing the nature of the action. The podcast for this class action lawsuit can be found here:

https://www.podbean.com/player-v2/?i=mj5ct-19ad352-pb&from=pb6admin&pbad=0&share=1&download=1&rtl=0&fonts=Arial&skin=1&font-color=auto&logo_link=episode_page&btn-skin=7

The filed complaint alleges that defendants made false statements and/or concealed that: (a) Baxter's recently launched product, the Novum LVP, suffered systemic defects that caused widespread malfunctions, including underinfusion, overinfusion, and complete non-delivery of fluids, which exposed patients to risks of serious injury or death; (b) Baxter was notified of multiple device malfunctions, injuries, and deaths from these defects; (c) Baxter's attempts to address these defects through customer alerts were inadequate remedial measures, when design flaws persisted and continued to cause serious harm to patients; (d) as a result, there was a heightened risk that customers would be instructed to take existing Novum LVPs out of service and that Baxter would completely pause all new sales of these pumps; and (e) based on the foregoing, Baxter's statements about the safety, efficacy, product rollout, customer feedback and sales prospects of the Novum LVPs were materially false and misleading.

If you have any questions about this class action lawsuit or any other sudden or unexpected stock loss, feel free to contact Levi & Korsinsky at (212)-363-7500.

You can also find recent podcasts regarding other class actions lawsuits and topics which are of interest to shareholders that have lost money in the stock market, here:

https://suewallst.podbean.com/

LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

Ed Korsinsky, Esq.

33 Whitehall Street, 27th Floor

New York, NY 10004

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

https://zlk.com/

SOURCE: Levi & Korsinsky, LLP

View the original press release on ACCESS Newswire